Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3607

LikeLikedUnlike

16-30 of 958

Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
CME/CE
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
- Richard Lafayette, MD, FACP
  Peer
- Ankana Daga, MD
  Peer
0.25 credits
CME/CE In-Person & Virtual Event
Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
May 28, 2026
Miami Beach, Florida
1.00 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
- Antoine Lanot, MD, PhD
  Peer
- Gil Yosipovitch, MD
  Peer
0.25 credits
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
- Mariana C. Castells, MD, PhD
  Peer
- Tsewang Tashi, MD
  Peer
0.25 credits
The Future of HNSCC: Aligning Teams, Transforming Care
CME/CE
The Future of HNSCC: Aligning Teams, Transforming Care
- Ravindra Uppaluri, MD, PhD
  Peer
- Nancy Lee, MD, FASTRO
  Peer
0.25 credits
Targeting Epicardial Adipose Tissue in Patients With HFpEF Without Diabetes: Sotagliflozin Effect From SOTA-P-CARDIA Trial Sub-Analysis
Cardiology
Targeting Epicardial Adipose Tissue in Patients With HFpEF Without Diabetes: Sotagliflozin Effect From SOTA-P-CARDIA Trial Sub-Analysis
- Juan Badimon, PhD, FAHA
  Peer
advertisement
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CE
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
- Maria Pabon, MD
  Peer
- Robert J. Mentz, MD, FHFSA, FACC
  Peer
0.25 credits
MinuteCE®
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
- Ahmad Masri, MD, MS
  Peer
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 credits 6 episodes
Cracking the Code of Obstruction: Unmet Needs in oHCM
MinuteCE®
Cracking the Code of Obstruction: Unmet Needs in oHCM
- Michael Nassif, MD, MSc
  Peer
1.00 program credits
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
MinuteCE®
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
Molecular Precision: How Myosin Inhibitors Redefine Control
MinuteCE®
Molecular Precision: How Myosin Inhibitors Redefine Control
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
MinuteCE®
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
advertisement
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
- Christyn Edmundson, MD
  Peer
- Gil I. Wolfe MD, FAAN
  Peer
1.00 credits 10 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended